Toxic pneumonitis from nebulised anti-microbials in home humidifiers

Yangho Kim (Ulsan, Republic of Korea)

Source: International Congress 2015 – Emerging occupational and environmental lung hazards: from asthma to interstitial disease
Disease area: Airway diseases, Interstitial lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yangho Kim (Ulsan, Republic of Korea). Toxic pneumonitis from nebulised anti-microbials in home humidifiers. International Congress 2015 – Emerging occupational and environmental lung hazards: from asthma to interstitial disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchospasm secondary to nebulised antibiotics in bronchiectasis
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017


Adherence to inhaled steroids treatment using smart nebulisers in severe asthmatics
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Risks of pneumonia in asthmatic patients taking inhaled corticosteroids
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Radiation pneumonitis in an infant treated with systemic and inhaled steroids
Source: Eur Respir J 2006; 28: Suppl. 50, 90s
Year: 2006

Toxic gas inhalation during the use of house cleaning materials
Source: Eur Respir J 2006; 28: Suppl. 50, 699s
Year: 2006

Acute pneumonitis after inhalation of water repelling spray: A diagnostic challenge
Source: Annual Congress 2010 - Chemical exposures and respiratory effects
Year: 2010


Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018
Year: 2019



Cotton, other bioaerosols, inhalation fevers and occupational organising pneumonia
Source: Eur Respir Monogr 2020; 89: 211-226
Year: 2020


Respiratory and neurological risks due to toxic and irritant gases in imported fright containers and goods
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008

Children rhinosinusitis nebulizer inhalation therapy
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009


Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Study of adherence to the use of inhaled sodium colistimethate through the I-neb® nebulization system
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Pulmonary toxicity in car spray painters
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011


Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria
Source: Eur Respir J 2011; 38: 486-487
Year: 2011


Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria
Source: Eur Respir J 2011; 38: 487-488
Year: 2011


Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Efficacy of nebulised adrenaline and salbutamol on mild to moderate bronchiolitis
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003


Hypersensitivity pneumonitis due to isocyanate exposure in an airbag “welder”
Source: Eur Respir Rev 2012; 21: 168-169
Year: 2012


Co-dispensing of inhaled corticosteroids and antibiotics
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012

Acute eosinophilic pneumonia due to heroin inhalation
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018